Recent Updates — ATEC

Alphatec Holdings reported third-quarter revenue of $221 million, a 13% increase year-over-year, driven by a 14% rise in surgical revenue to $202 million. Case volumes grew 20%, and net new surgeon users increased 25%. The company posted a GAAP net loss of $5 million but reported non-GAAP net income of $15 million and adjusted EBITDA of $38 million. Management cited lower biologics attachment as the primary reason for missing internal expectations, though hardware revenue grew 17%. Alphatec updated its full-year 2026 financial outlook, now expecting total revenue of approximately $862 million and adjusted EBITDA of approximately $137 million. The company operates in the medical device industry, specializing in innovative spine surgery solutions.

Alphatec Holdings reported second quarter financial results for the period ended June 30, 2026, showing total revenue of $214 million, a 15% year-over-year increase. Surgical revenue reached $196 million, up 17%, driven by 20% case volume growth and a 24% increase in net new surgeon users. The company reported GAAP net loss of $26 million but achieved Non-GAAP net income of $11 million and adjusted EBITDA of $36 million. Alphatec reaffirmed its full-year 2026 revenue outlook of approximately $882 million while increasing its adjusted EBITDA guidance to approximately $140 million from the prior expectation of $134 million, citing improved operating leverage. The company also expects at least $20 million in free cash flow for the fiscal year. Alphatec Holdings operates in the medical device industry, specializing in innovative spine surgery solutions and technologies.